Trial Profile
A Study to Evaluate the Safety and Effectiveness of Bedaquiline in Patients With Drug Resistant Tuberculosis in High HIV Prevalence Setting
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 11 May 2016 New trial record